Avoro Capital Advisors’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,000,000
| Closed | -$688M | – | 49 |
|
|
2021
Q3 | $688M | Buy |
4,000,000
+1,000,000
| +33% | +$131M | 10.82% | 3 |
|
|
2021
Q2 | $376M | Hold |
3,000,000
| – | – | 6.55% | 4 |
|
|
2021
Q1 | $407M | Buy |
3,000,000
+1,450,000
| +94% | +$187M | 7.03% | 4 |
|
|
2020
Q4 | $198M | Buy |
1,550,000
+200,000
| +15% | +$23.5M | 3.42% | 10 |
|
|
2020
Q3 | $152M | Buy |
1,350,000
+310,000
| +30% | +$30.9M | 2.16% | 11 |
|
|
2020
Q2 | $99.1M | Buy |
1,040,000
+180,000
| +21% | +$17.4M | 1.96% | 17 |
|
|
2020
Q1 | $77.3M | Buy |
+860,000
| New | +$66.8M | 2.61% | 14 |
|